Parameters of disease progression in long-term experimental feline retrovirus (feline immunodeficiency virus and feline leukemia virus) infections: Hematology, clinical chemistry, and lymphocyte subsets

Clinical and Diagnostic Laboratory Immunology

Volumn 4, Issue 1, 1997, Pages 33-42

  Hofmann Lehmann, Regina ^a   Holznagel, Edgar ^a   Ossent, Pete ^a   Lutz, Hans ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL CHEMISTRY; FELINE IMMUNODEFICIENCY VIRUS; FELINE LEUKEMIA VIRUS; HEMATOLOGY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0031055024     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.4.1.33-42.1997     Document Type: Article

References (72)

1. Ackley, C. D., J. K. Yamamoto, N. Levy, N. C. Pedersen, and M. D. Cooper. 1990. Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus. J. Virol. 64:5652-5655.
2. Alvarez, C., and A. Ramox. 1986. Lipids, lipoproteins, and apoproteins in serum during infection. Clin. Chem. 32:142-145.
3. Amadori, A., and L. Chieco-Bianchi. 1990. B-cell activation and HIV-1 infection: deeds and misdeeds. Immunol. Today 11:374-379.
4. Beisel, W. R. 1981. Impact of infectious disease upon fat metabolism and immune functions. Cancer Res. 41:3797-3798.
5. Beisel, W. R., and R. H. Fiser. 1970. Lipid metabolism during infectious illness. Am. J. Clin. Nutr. 23:1069-1079.
6. Bendinelli, M., M. Pistello, S. Lombardi, A. Poli, C. Garzelli, D. Matteucci, L Ceccherini-Nelli, G. Malvaldi, and F. Tozzini. 1995. Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clin. Microbiol. Rev. 8:87-112.
7. Cotter, S. M., W. D. Hardy, Jr., and M. Essex. 1975. Association of feline leukemia virus with lymphosarcoma and other disorders in the cat. J. Am. Vet. Med. Assoc. 166:449-454.
8. Day, N. K., C. O'Reilly-Felice, W. D. Hardy, R. A. Good, and S. S. Witkin. 1980. Circulating immune complexes associated with naturally occurring lymphosarcoma in pet cats. J. Immunol. 126:2363-2366.
9. Edgington, T. S., and L. K. Curtiss. 1981. Plasma lipoproteins with bioregulatory properties including the capacity to regulate lymphocyte function and the immune response. Cancer Res. 41:3786-3788.
10. Gardner, M. B. 1991. Simian and feline immunodeficiency viruses: animal lentivirus models for evaluation of AIDS vaccines and antiviral agents. Antiviral Res. 15:267-286.
11. Grinspoon, S. K., D. S. Donovan, and J. P. Bilezikian. 1994. Aetiology and pathogenesis of hormonal and metabolic disorders in HIV infection. Baillière's Clin. Endocrinol. Metab. 8:735-755.
12. Grunfeld, C., and K. R. Feingold. 1991. The metabolic effects of tumor necrosis factor and other cytokines. Biotherapy 3:143-148.
13. Grunfeld, C., M. Pang, W. Doerrler, J. K. Shigenaga, P. Jensen, and K. R. Feingold. 1992. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J. Clin. Endocrinol. Metab. 74:1045-1052.
14. Hardy, W. D. 1980. Feline leukemia virus disease, p. 3-31. in W. D. Hardy, M. Essex, and J. A. McClelland (ed.), Developments in cancer research. Elsevier Scientific Publishing Company, Amsterdam, The Netherlands.
15. Hellerstein, M. K., C. Grunfeld, K. Wu, M. Christiansen, S. Kaempfer, C. Kletke, and H. L. Shackleton. 1993. Increased de novo hepatic lipogenesis in human immunodeficiency virus infection. J. Clin. Endocrinol. Metab. 76: 559-565.
16. Holznagel, E., E. Niederer, R. Hofmann-Lehmann, C. Leutenegger, B. Willett, M. Franchini, and H. Lutz. Unpublished data.
17. Hopper, C. D., A. H. Sparkes, T. J. Grulfyd-Jones, S. M. Crispin, P. Muir, D. A. Harbour, and C. R. Stokes. 1989. Clinical and laboratory findings in cats infected with feline immunodeficiency virus. Vet. Rec. 125:341-346.
18. Hosie, M. J. 1994. The development of a vaccine against feline immunodeficiency virus. Br. Vet. J. 150:25-39.
19. Ishida, T., A. Taniguchi, S. Matsumura, T. Washizu, and I. Tomoda. 1992. Long-term clinical observations on feline immunodeficiency virus infected asymptomatic carriers. Vet. Immunol. Immunopathol. 35:15-22.
20. Ishida, T., and I. Tomoda. 1990. Clinical staging of feline immunodeficiency virus infection. Jpn. J. Vet. Sci. 52:545-648.
21. Jakowski, R. M., M. Essex, W. D. Hardy, J. R. Stephenson, and S. M. Cotter. 1980. Membranous glomerulonephritis in a household of cats persistently viremic with feline leukemia virus, p. 141-149. In W. D. Hardy, M. Essex, and A. J. McClelland (ed.), Developments in cancer research. Elsevier Scientific Publishing Company, Amsterdam, The Netherlands.
22. Jarrett, O., J. K, Yamamoto, and J. C. Neil. 1990. Feline immunodeficiency virus as a model for AIDS vaccination. AIDS 4(Suppl. 1):S163-S165.
23. Jarrett, W. F., E. M. Crawford, W. M. Martin, and F. Davie. 1964. A virus-like particle associated with leukaemia (lymphosarcoma). Nature 202: 567-568.
24. Klotz, F. W., and M. D. Cooper. 1986. A feline thymocyte antigen defined by a monoclonal antibody (FT2) identifies a subpopulation of non-helper cells capable of specific cytotoxicity. J. Immunol. 136:2510-2514.
25. Lafrado, L. J., M. G. Lewis, L. E. Mathes, and R. G. Olsen. 1987. Suppression of in vitro neutrophil function by feline leukaemia virus (FeLV) and purified FeLV-p15E. J. Gen. Virol. 68:507-513.
26. Lane, H. C., H. Masur, and L. C. Edgar. 1983. Abnormalities of B cell activation and immunoregulation in patients with acquired immunodeficiency syndrome. N. Engl. J. of Med. 309:453-458.
27. Lees, R. S., R. H. Fiser, W. R. Beisel, and P. J. Bartonelli. 1972. Effects of an experimental viral infection on plasma lipid and lipoprotein metabolism. Metabolism 21:825-833.
28. Lehmann, R., M. Franchini, A. Aubert, C. Wolfensberger, J. Cronier, and H. Lutz. 1991. Vaccination of cats experimentally infected with feline immuno-deficiency virus, using a recombinant feline leukemia virus vaccine. J. Am. Vet. Med. Assoc. 199:1445-1452.
29. + ratio in cats experimentally infected with feline immunodeficiency virus. Vet. Immunol. Immunopathol. 35:199-214.
30. Levy, J. A. 1989. Human immunodeficiency viruses and the pathogenesis of AIDS. JAMA 261:2997-3006.
31. Linenberger, M. L., A. M. Beebe, N. C. Pedersen, J. L. Abkowitz, and S. Dandekar. 1995. Marrow accessory cell infection and alterations in hematopoiesis accompany severe neutropcnia during experimental acute infection with feline immunodeficiency virus. Blood 85:941-951.
32. Lutz, H. 1984. Die Infektion mit felinem Leukämicvirus: Immunologie und Serodiagnostik als Grundlage der Infektionsbekämpfung. Schweiz. Arch. Tierheilkd. 126:1-22.
33. Lutz, H., P. Arnold, U. Hubscher, M. Egberink, N. Pedersen, and M. C. Horzinek. 1988. Specificity assessment of feline T-lymphotropic lentivirus serology. J. Vet. Med. Ser. B 35:773-778.
34. Lutz, H., H. Egberink, P. Arnold, G. Winkler, C. Wolfensberger, O. Jarrett, A. L. Parodi, N. C. Pedersen, and M. C. Horzinek, 1988. Felines T-lymphotropes Lentivirus (FTLV): Experimentelle Infektion und Vorkommen in einigen Ländern Europas. Kleintierpraxis 33:445-492.
35. Lutz, H., R. Hofmann-Lehmann, C. Leutenegger, K. Allenspach, A. M. Cuisinier, J. Cronier, V. Duquesne, and A. Aubert. 1996. Vaccination of cats with recombinant envelope glycoprotein of feline immunodeficiency virus: decreased viral load after challenge infection. AIDS Res. Hum. Retrovirus 12:431-433.
36. Lutz, H, R. Lehmann, G. Winkler, B. Kottwitz, A. Dittmer, C. Wolfensberger, and P. Arnold. 1990. Das feline Immunschwächevirus in der Schweiz: Klinik und Epidemiologie im Vergleich mit dem Leukämie- und dem Coronavirus. Schweiz. Arch. Tierheilkd. 132:217-225.
37. Lutz, H., N. C. Pedersen, R. Durbin, and G. H. Theilen. 1983. Monoclonal antibodies to three epitopic regions of feline leukemia virus p27 and their use in enzyme-linked immunosorbent assay of p27. J. Immunol. Methods 56: 209-220.
38. Madewell, B. R., and O. Jarrett. 1983. Recovery of feline leukaemia virus from non-viraemic cats. Vet. Rec. 112:339-342.
39. Marciani, D. J., C. R. Kensil, G. A. Beltz, C. H. Hung, J. Cronier, and A Aubert. 1991. Genetically-engineered subunit vaccine against feline leukaemia virus: protective immune response in cats. Vaccine 9:89-96.
40. Mathes, L. E., R. G. Olsen, L. C. Hebebrand, E. A. Hoover, J. P. Schaller, P. W. Adams, and W. S. Nichols. 1979. Immunosuppressive properties of a virion polypeptide, a 15,000-dalton protein, from feline leukemia virus. Cancer Res. 39:950-955.
41. McClelland, A. J., W. R. Hardy, and E. E. Zuckerman. 1980. Prognosis of healthy feline leukemia virus infected cats, p. 121-126. In W. D. Hardy, M. Essex, and A. J. McClelland (ed.), Development in cancer research. Elsevier Scientific Publishing Company, Amsterdam, The Netherlands.
42. McNeil, D. 1977. Interactive data analysis. John Wiley & Sons, Inc., New York, N.Y.
43. Meenau, J., E. Mooney, N. Mosquita, A. H. Johnson, P. Collins, J. Feely, and F. M. Mulcahy. 1992. The impact of HIV disease progression on serum lipoproteins. AIDS 6:1551-1552.
44. Miller, T. L., H. S. Winter, L. M. Luginbuhl, E. J. Orav, and K. McIntosh. 1992. Pancreatitis in pediatric human immunodeficiency virus infection. J. Pediat. 120:223-227.
45. Mochizuki, M., and O. Jarrett. 1985. Haemadsorption and haemagglutination by feline leukaemia viruses. J. Gen. Virol. 66:385-389.
46. Morikawa, S., H. Lutz, A. Aubert, and D. H. Bishop. 1991. Identification of conserved and variable regions in the envelope glycoprotein sequences of two feline immunodeficiency viruses isolated in Zurich, Switzerland. Virus Res. 21:53-63.
47. Onions, D., O. Jarrett, N. Testa, F. Frassoni, and S. Toth. 1982. Selective effect of feline leukaemia virus on early erythroid precursors. Nature 296: 156-158.
48. Pedersen, N. C., E. W. Ho, M. L. Brown, and J. K. Yamamoto. 1987. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235:790-793.
49. Pedersen, N. C., G. Theilen, M. A. Keane, L. Fairbanks, T. Mason, B. Orser, C. H. Che, and C. Allison. 1977. Studies of naturally transmitted feline leukemia virus infection. Am. J. Vet. Res. 38:1523-1531.
50. Pedersen, N. C., M. Torten, B. Rideout, E. Sparger, T. Tonachini, P. A. Luciw, C. Ackley, N. Levy, and J. Yamamoto. 1990. Feline leukemia virus infection as a potentiating cofactor for the primary and secondary stages of experimentally induce feline immunodeficiency virus infection. J. Virol. 64: 598-606.
51. Poli, A., F. Abramo, E. Taccini, G. Guidi, P. Barsotti, M. Bendinelli, and G. Malvaldi. 1993. Renal involvement in FIV infection: a clinicopathological study. Nephron 64:282-288.
52. Poli, A., M. L. Falcone, L. Bigalli, C. Massi, R. Hofmann-Lehmann, S. Lombardi, M. Bendinelli, and H. Lutz. 1995. Circulating immune complexes and analysis of renal immune deposits in feline immunodeficiency virus-infected cats. Clin. Exp. Immunol. 101:254-258.
53. Quackenbush, S. L., P. R. Donahue, G. A. Dean, M. H. Mytes, C. D. Ackley, M. D. Cooper, J. I. Mullins, and E. A. Hoover. 1990. Lymphocyte subset alterations and viral determinants of immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS. J. Virol. 64:5465-5474.
54. Reinacher, M., and K. Frese. 1991. Untersuchungen zur Glomerulonephritis bei Hund und Katze. Tierarztl. Praxis 19:175-180.
55. Sammalkorpi, K., V. Valtonen, Y. Kerttula, E. Nikkila, and M. R. Taskinen. 1988. Changes in serum lipoprotein pattern induced by acute infections. Metabolism 37:859-865.
56. Schnittmann, S. M., H. C. Lane, S. E. Higgins, T. Folks, and A. S. Fauci. 1986. Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus. Science 233:1084-1086.
57. Shelton, G. H., M. L. Linenberger, and J. L. Abkowitz. 1991. Hematologic abnormalities in cats seropositive for feline immunodeficiency virus. J. Am. Vet. Med. Assoc. 199:1353-1357.
58. Shelton, G. H., M. L. Linenberger, M. T. Persik, and J. L. Abkowitz. 1995. Prospective hematologic and clinicopathological study of asymptomatic cats with naturally acquired feline immunodeficiency virus-infection. J. Vet. Intern. Mcd. 9:133-140.
59. Shelton, G. H., J. L. Abkowitz, M. L. Linenberger, R. G. Russell, and C. K. Grant. 1989. Chronic leukopenia associated with feline immunodeficiency virus infection in a cat. J. Am. Vet. Med. Assoc. 194:253-255.
60. Shor-Posner, G., A. Basil, Y. Lu, C. Cabrejos, J. Chang, M. Fletcher, E. Mantero-Atienza, and M. K. Baum. 1993. Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection. Am. J. Med. 94:515-519.
61. Snyder, H. W., F. R. Jones, N. K. Day, and W. D. Hardy. 1982. Isolation and characterization of circulating feline leukemia virus-immune complexes from plasma of persistently infected pet cats removed by ex vivo immunosorption. J. Immunol. 128:2726-2730.
62. Sparkes, A. H., C. D. Hopper, W. G. Millard, T. J. Gruffydd-Jones, and D. A. Harbour. 1993. Feline immunodeficiency virus infection. Clinicopathologic findings in 90 naturally occurring cases. J. Vet. Intern. Med. 7:85-90.
63. Testa, N. G., D. Onions, O. Jarrett, F. Frassoni, and J. F. Eliason. 1983. Haemopoietic colony formation (BFU-E, GM-CFC) during the development of pure red cell hypoplasia induced in the cat by feline leukaemia virus. Leukocyte Res. 7:103-116.
64. Thomas, J. B., W. F. Robinson, B. J. Chadwick, I. D. Robertson, and P. S. Jones. 1993. Leukogram and biochemical abnormalities in naturally occurring feline immunodeficiency virus infection. J. Am. Anim. Hosp. Assoc. 29:272-278.
65. Tieze, N. W. 1995. Clinical guide to laboratory tests. The W. B. Saunders Co., Philadelphia, Pa.
66. Tompkins, M. B., P. D. Nelson, R. V. English, and C. Novotney. 1991. Early events in the immunopathogenesis of feline retrovirus infections. J. Am. Vet. Med. Assoc. 199:1311-1315.
67. Trainin, Z., H. Ungar-Waron, and M. Essex. 1983. Suppression of the humoral antibody response in natural retrovirus infections. Science 220:858-859.
68. Walker, C., P. J. Canfield, and D. N. Love. 1994. Analysis of leucocytes and lymphocyte subsets for different clinical stages of naturally acquired feline immunodeficiency virus infection. Vet. Immunol. Immunopathol. 44:1-12.
69. Weijer, K., and J. H. Daams. 1976. The presence of leukaemia (lymphosarcoma) and feline leukaemia virus (FeLV) in cats in the Netherlands. J. Small. Anim. Pract. 17:649-659.
70. Weinroth, S. E., D. M. Parenti, and G. L. Simon. 1995. Wasting syndrome in AIDS: pathophysiologic mechanisms and therapeutic approaches. Infect. Agents Dis. 4:76-94.
71. Wolf, P., J. R. Reiser, J. E. Fellow, and P. Haghighi. 1989. Pancreatitis in patients with AIDS presumptively due to CMV. J. Clin. Lab. Anal. 3:152-155.
72. Yamamoto, J. K., H. Hansen, E. W. Ho, T. Y. Morishita, T. Okuda, T. R. Sawa, R. M. Nakamura, and N. C. Pedersen. 1989. Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission. J. Am. Vet. Med. Assoc. 194:213-220.